Zobrazeno 1 - 10
of 99
pro vyhledávání: '"J, Imeson"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrew D.J. Pearson, J. Imeson, Ian Lewis, C. Ross Pinkerton, Lucas Moreno, Sucheta Vaidya, David Machin
Publikováno v:
Pediatric Blood & Cancer. 60:1135-1140
Background Therapy for high-risk neuroblastoma is intensive and multimodal, and significant long-term adverse effects have been described. The aim of this study was to identify the nature and severity of late complications of metastatic neuroblastoma
Publikováno v:
The Lancet Oncology. 9:247-256
Summary Background The current standard treatment for patients with high-risk neuroblastoma includes initial induction chemotherapy with a 21-day interval between induction treatments. We aimed to assess whether an intensive chemotherapy protocol tha
Autor:
J. Imeson, Jenny Walker, Peter Gornall, Roger E. Taylor, Boo Messahel, Pat Sartori, Rosemary S. Shannon, Anna Kelsey, Jon Pritchard, Carolyn Hutton, Suzanne Stevens, Kathy Pritchard-Jones, Helen Middleton, Chris Mitchell, Juliet Hale, David Machin, Gordan M. Vujanic, Gill Levitt, Richard Grundy
Publikováno v:
European Journal of Cancer. 42:2554-2562
Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: Results of a randomised trial (UKW3) by the UK Children's Cancer Study Group Purpose: To determine if patients receiving preoperative chemothera
Autor:
Neil D. Shaw, Chris Philpott, Dawn Leese, A.Martin Barrett, Barry L. Pizer, Kevin Windebank, J. Imeson
Publikováno v:
Journal of Pediatric Surgery. 39:1520-1523
Background The authors report the results of a prospective, multicenter, multidisciplinary study of central venous catheters (CVCs) in pediatric oncology patients analyzing factors involved in early failure. Methods Information was collected from par
Autor:
J. Imeson, Gordan M. Vujanic, Richard Grundy, Helen Middleton, H.B. Marsden, Anna Kelsey, Jon Pritchard, Roger E. Taylor, C. Hutton
Publikováno v:
Pediatric Blood & Cancer. 42:311-319
Background The aims of UKWT2 included consolidating the results for stage III patients obtained in UKWT1 and improving the outcome for patients with inoperable tumours by giving vincristine, actinomycin-D and doxorubicin in an intensive schedule (Int
Publikováno v:
British Journal of Haematology. 121:586-591
We have examined the outcome for children treated on two consecutive United Kingdom Children's Cancer Study Group studies of localized B-cell non-Hodgkin's lymphoma (NHL). The first study (NHL 8501; 1985-1989) included cyclophosphamide in the treatme
Autor:
Roger E. Taylor, David W. Ellison, J. Imeson, James W. Ironside, Clifford C. Bailey, H Lucraft, Linda S Lashford, Barry Pizer, Claire Weston, David Walker, Richard J. Gilbertson, Diana Tait, K. Robinson
Publikováno v:
Journal of Clinical Oncology. 21:1581-1591
Purpose: To determine whether preradiotherapy (RT) chemotherapy would improve outcome for Chang stage M0–1 medulloblastoma when compared with RT alone. Chemotherapy comprised vincristine 1.5 mg/m2 weekly for 10 weeks and four cycles of etoposide 10
Autor:
Simon N. Huddart, J. Imeson, F. Raafat, P. Gornall, K. Robinson, A. Oakhill, P. McKeever, Jillian R. Mann, E. Gray, M. Sokal
Publikováno v:
Pediatric Surgery International. 19:47-51
The aim of this study was to review the United Kingdom Children's Cancer Study Group (UKCCSG) experience of sacrococcygeal teratomas (SCT) including histological presentation, response to surgery and chemotherapy, and long term effects of the tumour
Autor:
A Atra, Elizabeth Higgs, Martin Hewitt, J. Imeson, Ann Elsworth, Michael Capra, Martin Radford
Publikováno v:
British Journal of Haematology. 119:647-651
Summary. We reviewed the results of two consecutive United Kingdom Childrens' Cancer Study Group (UKCCSG) studies of children with stage IV Hodgkin's Disease (HD) treated between January 1982 and December 1999. Among 697 children with HD, 67 were dia